Skip to main content
SpringerLink
Log in

Toxic Neuropathies

  • Chapter
  • First Online:
Acquired Neuromuscular Disorders

  • 491 Accesses

Abstract

Several toxic agents have an easy access to the peripheral nervous system. These toxic substances belong to different classes, including therapeutic drugs, recreational abuse substances, environmental and industrial contaminants.

Establishment of a real causal relationship between peripheral nervous system damage and toxic agents exposure is obvious in some condition (e.g., in the course of anticancer chemotherapy), but it can be very difficult or even misleading in other contexts, when potential exposure is not easy to be proven or is not reported by the affected subjects.

Not all the reports describing the peripheral toxicity of substances causing rare events are convincing, and the list of putative neurotoxic agents is probably over-estimated. Nevertheless, relationship even with agents with only occasional neurotoxicity has been clearly established.

The clinical effects of the exposure to neurotoxic agents are highly variable, depending on the mechanism of their action and on the intracellular target. In most cases, sensory impairment is exclusive or largely predominant over motor or autonomic damage. Similarly, the clinical course may be acute, subacute, or chronic and recovery after withdrawal from toxic exposure is not always guaranteed. Moreover, worsening lasting months after the suspension of toxic exposure (the “coasting effect”) has also been reported. Despite the typical clinical features are those of distal, symmetrical polyneuropathy, local application of neurotoxic agents may induce focal mononeuropathies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bal-Price A, Lein PJ, Keil KP, Sethi S, Shafer T, Barenys M, Fritsche E, Sachana M, Meek MEB. Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity. Neurotoxicology. 2017;59:240–55.

    Article  CAS  PubMed  Google Scholar 

  2. Weimer LH, Sachdev N. Update on medication-induced peripheral neuropathy. Curr Neurol Neurosci Rep. 2009;9:69–75.

    Article  CAS  PubMed  Google Scholar 

  3. Arezzo JC, Litwak MS, Zotova EG. Correlation and dissociation of electrophysiology and histopathology in the assessment of toxic neuropathy. Toxicol Pathol. 2011;39:46–51.

    Article  PubMed  Google Scholar 

  4. DeGrandchamp RL, Lowndes HE. Early degeneration and sprouting at the rat neuromuscular junction following acrylamide administration. Neuropathol Appl Neurobiol. 1990;16:239–54.

    Article  CAS  PubMed  Google Scholar 

  5. Marmiroli P, Nicolini G, Miloso M, Scuteri A, Cavaletti G. The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity. Ital J Anat Embryol. 2012;117:75–97.

    PubMed  Google Scholar 

  6. Grisold W, Cavaletti G, Windebank AJ. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol. 2012;14 Suppl 4:iv45–54.

    PubMed  Google Scholar 

  7. Cavaletti G, Alberti P, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics. Lancet Oncol. 2011;12:1151–61.

    Article  CAS  PubMed  Google Scholar 

  8. Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol. 2010;6:657–66.

    Article  PubMed  Google Scholar 

  9. Carozzi VA, Chiorazzi A, Canta A, Meregalli C, Oggioni N, Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: new useful ready-to-use animal models. Exp Neurol. 2015;264:92–102.

    Article  CAS  PubMed  Google Scholar 

  10. Carozzi VA, Canta A, Oggioni N, Sala B, Chiorazzi A, Meregalli C, Bossi M, Marmiroli P, Cavaletti G. Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies. Exp Neurol. 2010;226:301–9.

    Article  CAS  PubMed  Google Scholar 

  11. Bennett GJ, Doyle T, Salvemini D. Mitotoxicity in distal symmetrical sensory peripheral neuropathies. Nat Rev Neurol. 2014;10:326–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Meregalli C, Chiorazzi A, Carozzi VA, Canta A, Sala B, Colombo M, Oggioni N, Ceresa C, Foudah D, La Russa F, Miloso M, Nicolini G, Marmiroli P, Bennett DL, Cavaletti G. Evaluation of tubulin polymerization and chronic inhibition of proteasome as cytotoxicity mechanisms in bortezomib-induced peripheral neuropathy. Cell Cycle. 2014;13:612–21.

    Article  CAS  PubMed  Google Scholar 

  13. Cavaletti G, Ceresa C, Nicolini G, Marmiroli P. Neuronal drug transporters in platinum drugs-induced peripheral neurotoxicity. Anticancer Res. 2014;34:483–6.

    CAS  PubMed  Google Scholar 

  14. Sprowl JA, Ciarimboli G, Lancaster CS, Giovinazzo H, Gibson AA, Du G, Janke LJ, Cavaletti G, Shields AF, Sparreboom A. Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2. Proc Natl Acad Sci U S A. 2013;110:11199–204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Sprowl JA, Lancaster CS, Pabla N, Hermann E, Kosloske AM, Gibson AA, Li L, Zeeh D, Schlatter E, Janke LJ, Ciarimboli G, Sparreboom A. Cisplatin-induced renal injury is independently mediated by OCT2 and p53. Clin Cancer Res. 2014;20:4026–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Abbi KK, Rizvi SM, Sivik J, Thyagarajan S, Loughran T, Drabick JJ. Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: a case report and review of the literature. Leuk Res. 2010;34:e154–6.

    Article  PubMed  Google Scholar 

  17. Pastorelli F, Derenzini E, Plasmati R, Pellegrini C, Broccoli A, Casadei B, Argnani L, Salvi F, Pileri S, Zinzani PL. Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. Leuk Lymphoma. 2013;54:2318–21.

    Article  PubMed  Google Scholar 

  18. Johnson DB, Manouchehri A, Haugh AM, Quach HT, Balko JM, Lebrun-Vignes B, Mammen A, Moslehi JJ, Salem JE. Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study. J Immunother Cancer. 2019;7:134.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Orr CF, Ahlskog JE. Frequency, characteristics, and risk factors for amiodarone neurotoxicity. Arch Neurol. 2009;66:865–9.

    Article  PubMed  Google Scholar 

  20. Hao S. The molecular and pharmacological mechanisms of HIV-related neuropathic pain. Curr Neuropharmacol. 2013;11:499–512.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Manji H. Toxic neuropathy. Curr Opin Neurol. 2011;24:484–90.

    Article  CAS  PubMed  Google Scholar 

  22. Mellion M, Gilchrist JM, de la Monte S. Alcohol-related peripheral neuropathy: nutritional, toxic, or both? Muscle Nerve. 2011;43:309–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Koike H, Iijima M, Sugiura M, Mori K, Hattori N, Ito H, Hirayama M, Sobue G. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol. 2003;54:19–29.

    Article  PubMed  Google Scholar 

  24. Ramcharan K, Ramesar A, Ramdath M, Teelucksingh J, Gosein M. Encephalopathy and neuropathy due to glue, paint thinner, and gasoline sniffing in Trinidad and Tobago-MRI findings. Case Rep Neurol Med. 2014;2014:850109.

    PubMed  PubMed Central  Google Scholar 

  25. Sills RC, Harry GJ, Morgan DL, Valentine WM, Graham DG. Carbon disulfide neurotoxicity in rats: V. Morphology of axonal swelling in the muscular branch of the posterior tibial nerve and spinal cord. Neurotoxicology. 1998;19:117–27.

    CAS  PubMed  Google Scholar 

  26. Ghosh A. Evaluation of chronic arsenic poisoning due to consumption of contaminated ground water in West Bengal, India. Int J Prev Med. 2013;4:976–9.

    PubMed  PubMed Central  Google Scholar 

  27. Kim S, Takeuchi A, Kawasumi Y, Endo Y, Lee H, Kim Y. A Guillain-Barré syndrome-like neuropathy associated with arsenic exposure. J Occup Health. 2012;54:344–7.

    Article  CAS  PubMed  Google Scholar 

  28. Rice KM, Walker EM, Wu M, Gillette C, Blough ER. Environmental mercury and its toxic effects. J Prev Med Public Health. 2014;47:74–83.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Kingman A, Albers JW, Arezzo JC, Garabrant DH, Michalek JE. Amalgam exposure and neurological function. Neurotoxicology. 2005;26:241–55.

    Article  CAS  PubMed  Google Scholar 

  30. Thomson RM, Parry GJ. Neuropathies associated with excessive exposure to lead. Muscle Nerve. 2006;33:732–41.

    Article  CAS  PubMed  Google Scholar 

  31. Sondekoppam RV, Tsui BC. Factors associated with risk of neurologic complications after peripheral nerve blocks: a systematic review. Anesth Analg. 2017;124:645–60.

    Article  PubMed  Google Scholar 

  32. Sites BD, Taenzer AH, Herrick MD, Gilloon C, Antonakakis J, Richins J, Beach ML. Incidence of local anesthetic systemic toxicity and postoperative neurologic symptoms associated with 12,668 ultrasound-guided nerve blocks: an analysis from a prospective clinical registry. Reg Anesth Pain Med. 2012;37:478–82.

    Article  CAS  PubMed  Google Scholar 

  33. Jeng CL, Torrillo TM, Rosenblatt MA. Complications of peripheral nerve blocks. Br J Anaesth. 2010;105(Suppl 1):i97–i107.

    Article  PubMed  Google Scholar 

  34. Lupu CM, Kiehl TR, Chan VW, El-Beheiry H, Madden M, Brull R. Nerve expansion seen on ultrasound predicts histologic but not functional nerve injury after intraneural injection in pigs. Reg Anesth Pain Med. 2010;35:132–9.

    Article  PubMed  Google Scholar 

  35. Selander D, Brattsand R, Lundborg G, Nordborg C, Olsson Y. Local anesthetics: importance of mode of application, concentration and adrenaline for the appearance of nerve lesions. An experimental study of axonal degeneration and barrier damage after intrafascicular injection or topical application of bupivacaine (Marcain). Acta Anaesthesiol Scand. 1979;23:127–36.

    Article  CAS  PubMed  Google Scholar 

  36. Sturrock JE, Nunn JF. Cytotoxic effects of procaine, lignocaine and bupivacaine. Br J Anaesth. 1979;51:273–81.

    Article  CAS  PubMed  Google Scholar 

  37. Lirk P, Hollmann MW, Strichartz G. The science of local anesthesia: basic research, clinical application, and future directions. Anesth Analg. 2018;126:1381–92.

    Article  CAS  PubMed  Google Scholar 

  38. Yang S, Abrahams MS, Hurn PD, Grafe MR, Kirsch JR. Local anesthetic Schwann cell toxicity is time and concentration dependent. Reg Anesth Pain Med. 2011;36:444–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy

    Guido Cavaletti & Paola Marmiroli

Authors
  1. Guido Cavaletti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paola Marmiroli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guido Cavaletti .

Editor information

Editors and Affiliations

  1. Department Neurosciences, Neuromuscular Center, Campus Pietro d’Abano, University of Padova, Padova, Padova, Italy

    Corrado Angelini

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cavaletti, G., Marmiroli, P. (2022). Toxic Neuropathies. In: Angelini, C. (eds) Acquired Neuromuscular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-031-06731-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-06731-0_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-06730-3

  • Online ISBN: 978-3-031-06731-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation